MedTrace Logo

START: Swiss Taxotere Alopecia Prevention Trial

NCT01008774 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 239

Last updated 2012-01-23

No results posted yet for this study

Summary

Primary objective:

* Rate of complete chemotherapy induced alopecia (WHO grade III or IV, physician grading)

Secondary objective:

* Compliance to scalp cooling procedure
* Received number of cycles of chemotherapy in each subgroup
* Patient perception of scalp cooling procedure
* Side effects of scalp cooling systems

Conditions

Interventions

DEVICE

Paxman Cooling Machine

Scalp cooling procedures

DEVICE

Cold Caps

Scalp cooling procedures

Sponsors & Collaborators

Principal Investigators

  • Clinical Sciences & Operations · Sanofi

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01008774 on ClinicalTrials.gov